TABLE 2.

Steady-state pharmacokinetics of EFV with and without RMP^a

Treatment	Cmax	Cmin	Tmax	AUC(0-24)	CL	t1/2
EFV	9.88 ± 9.38	5.84 ± 7.54	2.53 ± 1.07	169.77 ± 205.34	7.25 ± 5.10	24.98 ± 13.19
EFV + RMP	8.12 ± 7.10	4.65 ± 5.80	2.47 ± 0.97	138.19 ± 148.28	9.27 ± 6.52	17.57 ± 9.42b

^aThe values shown are means ± standard deviations for 19 patients. T_max, time to attain C_max; t_1/2, half-life.

^bP < 0.05.